-
Study aim
-
Comparison effect of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration in reducing of amphotericin B-induced nephrotoxicity
-
Design
-
A clinical trial with a control group with parallel groups, single-blind, randomized and sampling groups was 40 patients. In this study, there was no factor in the classification of patients in the two groups.
-
Settings and conduct
-
A randomized, single-blind clinical trial will be carried out at the Shiraz University of Medical Sciences , Namazi Hospital. BUN and Scr values will be determined for each patient every other day during the study period (days 1, 3, 5 and 7). GFR will be also calculated every other day by MDRD formula. Serum potassium and magnesium levels will be determined at days 1 & 7 of the intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Age over 15 years, Receive amphotericin for at least 7 days, No history of kidney disease (including chronic kidney disease) and hemodialysis, Signing up the informed consent form
Exclusion criteria:
Cardiac failure class 3 and 4, Known liver failure, Known kidney failure, Alkalosis (pH greater than 7.5 or sodium bicarbonate plasma greater than 30 meq / lit), symptomatic Hypocalcemia, hypokalemia or hypomagnesemia, Sensitivity and any adverse effect that occurred after the injection of bicarbonate in the patient.
-
Intervention groups
-
group 1:Includes 20 patients with 1000 ml normal saline 0.9% equivalent to 159 mEq in two divided doses (500 ml) before and after infusion of amphotericin that is given to patients.
group2:Includes 20 patients who received 500 ml of normal saline before injection of amphotericin and 1.5 vial sodium bicarbonate vial in 500 cc dextrose water, equivalent to the normal saline mEq 159, sodium bicarbonate that is given to patients.
-
Main outcome variables
-
Nephrotoxicity of amphotericin B